Literature DB >> 34774558

Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury.

Yu Pan1, Shirong Cao2, Andrew S Terker2, Jiaqi Tang2, Kensuke Sasaki2, Yinqiu Wang2, Aolei Niu2, Wentian Luo2, Xiaofeng Fan2, Suwan Wang2, Matthew H Wilson2, Ming-Zhi Zhang3, Raymond C Harris4.   

Abstract

Following acute injury to the kidney, macrophages play an important role in recovery of functional and structural integrity, but organ fibrosis and progressive functional decline occur with incomplete recovery. Pro-resolving macrophages are characterized by increased cyclooxygenase 2 (COX-2) expression and this expression was selectively increased in kidney macrophages following injury and myeloid-specific COX-2 deletion inhibited recovery. Deletion of the myeloid prostaglandin E2 (PGE2) receptor, E-type prostanoid receptor 4 (EP4), mimicked effects seen with myeloid COX-2-/- deletion. PGE2-mediated EP4 activation induced expression of the transcription factor MafB in kidney macrophages, which upregulated anti-inflammatory genes and suppressed pro-inflammatory genes. Myeloid Mafb deletion recapitulated the effects seen with either myeloid COX-2 or EP4 deletion following acute kidney injury, with delayed recovery, persistent presence of pro-inflammatory kidney macrophages, and increased kidney fibrosis. Thus, our studies identified a previously unknown mechanism by which prostaglandins modulate macrophage phenotype following acute organ injury and provide new insight into mechanisms underlying detrimental kidney effects of non-steroidal anti-inflammatory drugs that inhibit cyclooxygenase activity. Published by Elsevier Inc.

Entities:  

Keywords:  AKI; cyclooxygenase 2; macrophage polarization; renal fibrosis

Mesh:

Substances:

Year:  2021        PMID: 34774558      PMCID: PMC8741730          DOI: 10.1016/j.kint.2021.09.033

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  52 in total

1.  Mitochondrial Membrane Potential Regulates Nuclear Gene Expression in Macrophages Exposed to Prostaglandin E2.

Authors:  David E Sanin; Mai Matsushita; Ramon I Klein Geltink; Katarzyna M Grzes; Nikki van Teijlingen Bakker; Mauro Corrado; Agnieszka M Kabat; Michael D Buck; Jing Qiu; Simon J Lawless; Alanna M Cameron; Matteo Villa; Francesc Baixauli; Annette E Patterson; Fabian Hässler; Jonathan D Curtis; Christina M O'Neill; David O'Sullivan; Duojiao Wu; Gerhard Mittler; Stanley Ching-Cheng Huang; Erika L Pearce; Edward J Pearce
Journal:  Immunity       Date:  2018-12-18       Impact factor: 31.745

2.  Vascular Smooth Muscle-Specific EP4 Receptor Deletion in Mice Exacerbates Angiotensin II-Induced Renal Injury.

Authors:  Jean-Francois Thibodeau; Chet E Holterman; Ying He; Anthony Carter; Gregory O Cron; Naomi C Boisvert; Khaled S Abd-Elrahman; Karolynn J Hsu; Stephen S G Ferguson; Christopher R J Kennedy
Journal:  Antioxid Redox Signal       Date:  2016-08-05       Impact factor: 8.401

3.  CSF-1 signaling mediates recovery from acute kidney injury.

Authors:  Ming-Zhi Zhang; Bing Yao; Shilin Yang; Li Jiang; Suwan Wang; Xiaofeng Fan; Huiyong Yin; Karlton Wong; Tomoki Miyazawa; Jianchun Chen; Ingrid Chang; Amar Singh; Raymond C Harris
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

4.  Emerging urinary biomarkers in the diagnosis of acute kidney injury.

Authors:  Prasad Devarajan
Journal:  Expert Opin Med Diagn       Date:  2008-04

5.  Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.

Authors:  C Nataraj; D W Thomas; S L Tilley; M T Nguyen; R Mannon; B H Koller; T M Coffman
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

6.  A mutation in transcription factor MAFB causes Focal Segmental Glomerulosclerosis with Duane Retraction Syndrome.

Authors:  Yoshinori Sato; Hiroyasu Tsukaguchi; Hiroyuki Morita; Koichiro Higasa; Mai Thi Nhu Tran; Michito Hamada; Toshiaki Usui; Naoki Morito; Shoichiro Horita; Takao Hayashi; Junko Takagi; Izumi Yamaguchi; Huan Thanh Nguyen; Masayo Harada; Kiyoko Inui; Yuichi Maruta; Yoshihiko Inoue; Fumihiko Koiwa; Hiroshi Sato; Fumihiko Matsuda; Shinya Ayabe; Seiya Mizuno; Fumihiro Sugiyama; Satoru Takahashi; Ashio Yoshimura
Journal:  Kidney Int       Date:  2018-05-18       Impact factor: 10.612

7.  Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor.

Authors:  Kiyoshi Takayama; Guillermo García-Cardena; Galina K Sukhova; Jason Comander; Michael A Gimbrone; Peter Libby
Journal:  J Biol Chem       Date:  2002-09-04       Impact factor: 5.157

8.  Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans.

Authors:  Ming-Zhi Zhang; Jie Xu; Bing Yao; Huiyong Yin; Qiuyin Cai; Martha J Shrubsole; Xiwu Chen; Valentina Kon; Wei Zheng; Ambra Pozzi; Raymond C Harris
Journal:  J Clin Invest       Date:  2009-03-23       Impact factor: 14.808

9.  EP4 Receptor-Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis.

Authors:  Masato Nakatsuji; Manabu Minami; Hiroshi Seno; Mika Yasui; Hideyuki Komekado; Sei Higuchi; Risako Fujikawa; Yuki Nakanishi; Akihisa Fukuda; Kenji Kawada; Yoshiharu Sakai; Toru Kita; Peter Libby; Hiroki Ikeuchi; Masayuki Yokode; Tsutomu Chiba
Journal:  PLoS Genet       Date:  2015-10-06       Impact factor: 5.917

10.  Scaling read aligners to hundreds of threads on general-purpose processors.

Authors:  Ben Langmead; Christopher Wilks; Valentin Antonescu; Rone Charles
Journal:  Bioinformatics       Date:  2019-02-01       Impact factor: 6.937

View more
  1 in total

1.  Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice.

Authors:  Yu Pan; Shirong Cao; Jiaqi Tang; Juan P Arroyo; Andrew S Terker; Yinqiu Wang; Aolei Niu; Xiaofeng Fan; Suwan Wang; Yahua Zhang; Ming Jiang; David H Wasserman; Ming-Zhi Zhang; Raymond C Harris
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.